TNX-201 35 mg
TNX-IS-T101
Phase 1 small_molecule completed
Quick answer
TNX-201 35 mg for Healthy is a Phase 1 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tonix Pharmaceuticals Holding
- Indication
- Healthy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed